Final Program

338 WEDNESDAY • MAY 18
Objectives
At the conclusion of this session, the participant will be able to:
• explore issues related to respiratory symptom managment and respiratory
symptom clusters with a focus on cough;
• identify a theoretical understanding of the relationship of psychologic symptoms
and chronic cough and to understand the role of speech pathology in the
managment of chronic cough;
• become aware of recent finding of systematic reviews and guidelines related to
the diagnosis and management of chronic refractory cough.
This session will use interprofessional inquiry and recent findings from the literature
to broaden the attendees understanding of the symptom of chronic cough and
refractory chronic cough and its management in 2016.
Chairing: P.M. Meek, RN, PhD, Denver, CO
A.M. Russell, MSc, London, United Kingdom
9:00 Reflections from Symptom Management
P.M. Meek, RN, PhD, Denver, CO
9:15 Respiratory Symptom Clusters
J. Yorke, PhD, RN, Manchester, United Kingdom
9:30 Examining Change in Symptoms of Depression, Anxiety, and
Stress in Adults After Treatment of Chronic Cough
C.L. French, PhD, RN, Worcester, MA
9:45 Update Refractory Chronic Cough and Management
P.G. Gibson, MBBS, Newcastle, Australia
10:00 The Role of the Speech Pathologist and Speech Pathology in
the Management of Chronic Cough
A.E. Vertigan, PhD, MBA, BAppSc(Sp.Path), Newcastle, Australia
10:15 Is the Refractory Cough of a Psychogenic Nature a Habit or an
Undiagnosed Tic Cough?
R.S. Irwin, MD, Worcester, MA
10:30 Panel Discussion
D6
CLINICAL • TRANSLATIONAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
CANNABIS, CANNABIMIMETICS, AND OPIATES IN
SLEEP AND BREATHING
Assemblies on Sleep and Respiratory Neurobiology; Behavioral Science and
Health Services Research; Pediatrics
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 2001/2003 (West Building, Level 2)
Target Audience
Pulmonologists, pediatricians, respiratory therapists, nurses practitioners,
sleep medicine research scientists, epidemiologists, public health providers
and health services researchers.
Objectives
At the conclusion of this session, the participant will be able to:
• discuss neurodevelopmental and respiratory effects of cannabis use in
adolescents and young adults;
• learn emerging data on effects of cannabis on sleep and novel therapeutic
applications of cannabimetic drugs in sleep related breathing;
• review effects of opioids on sleep related breathing and discuss ampakines;
a novel therapy for opioid induced respiratory depression.
Legalization of cannabis in the U.S. and other countries has led to increasing
medicinal and recreational use of cannabis. This symposium will describe the
known effects of cannabis on neurodevelopment of adolescents and its effects
on sleep. Current and potential therapeutic uses of cannabis and
cannabimimetics in sleep and breathing disorders will be discussed. Acute and
chronic use of opioids in hospitalized patients, perioperative settings and for
opioid use disorders is increasingly prevalent. Effects of opioids on sleep related
breathing and novel preclinical pharmacologic interventions to reverse opioid
effects on breathing will be reviewed.
Chairing: B. Prasad, MD, MS, Chicago, IL
L. Kheirandish-Gozal, MD, MSc, Chicago, IL
9:00 A Patient’s Perspective
J. Jorgensen, Vista, CA
9:05 Opioid-Induced Sleep Apnea: Precursor to Periodicity
S. Chowdhuri, MD, MS, Detroit, MI
9:25 Ampakine Therapy for Alleviating Opioid-Induced Respiratory
Depression
J.J. Greer, PhD, Edmonton, Canada
9:50 Cannabis and Human Sleep: What Have We Learned So Far?
K. Babson, PhD, Menlo Park, CA
10:10 Neurodevelopmental and Respiratory Effects of Cannabis in
Adolescents and Adults
R. Bhattacharjee, MD, San Diego, CA
10:25 Cannabinoids: Novel Translational Potential for Sleep Apnea
Therapy?
D.W. Carley, PhD, Chicago, IL
D7
There will be a 5-minute discussion after each talk.
BASIC • CLINICAL • TRANSLATIONAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
EXPLOITING GPCRS FOR NEW AND IMPROVED
ASTHMA MEDICINE
Assemblies on Respiratory Structure and Function; Allergy, Immunology
and Inflammation; Respiratory Cell and Molecular Biology
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 2002/2004 (West Building, Level 2)
Target Audience
Basic, translational and clinical scientists who wish to learn about the exciting
discoveries of new targets for asthma therapy, and how these targets are
being validated both in vitro and in vivo.
Objectives
At the conclusion of this session, the participant will be able to:
ATS 2016 • San Francisco